Fentanyl isn’t just another opioid. It’s up to 50 times stronger than heroin and 100 times more powerful than morphine. And right now, it’s the #1 driver of overdose deaths in the United States.
In 2022, fentanyl was linked to over 73,000 overdose deaths, according to the National Institute on Drug Abuse. It’s often mixed into other drugs like heroin, cocaine, or counterfeit pills and most users have no idea they’ve taken it.
This is a huge safety risk for industries that rely on alertness and focus, like transportation, construction, healthcare, and logistics.
Here’s the critical question: are your current drug tests even screening for it?
In most cases, they’re not.
Most employers still rely on 5-panel or 10-panel drug tests. These cover:
But they don’t include synthetic opioids like fentanyl or norfentanyl unless you explicitly request them. So, unless you’re using an expanded opioid panel, fentanyl is flying under the radar.
If your drug tests aren’t catching fentanyl, your program has a major blind spot. That opens the door to:
This risk is especially critical in:
In January 2025, the U.S. Department of Health and Human Services (HHS) issued a new rule that requires all certified labs to test for fentanyl and its metabolite, norfentanyl, in federal workplace drug tests.
This goes into effect July 7, 2025, and covers:
The DOT hasn’t adopted the rule yet, but that’s likely coming soon. When it does, all DOT-regulated employees will need to be compliant.
Adding fentanyl to your panel now is about more than just compliance, it’s about preventing loss, protecting lives, and getting ahead of policy shifts.
Here’s what you gain:
Fentanyl impairs coordination and decision-making. Catching it before it causes an incident protects your team.
If an incident happens and you weren’t testing for fentanyl, you may be seen as negligent. Updating your panel helps limit risk.
Expanding your panel signals to employees that you’re serious about health and safety.
Fentanyl is often taken unintentionally. Your test might be the first sign someone needs help.
Regulators are moving toward mandatory fentanyl testing. You’ll be ahead of the curve.
Some areas have seen a small dip in fentanyl deaths due to expanded naloxone access and public education. That doesn’t mean the threat is gone.
The DEA and CBP are still seizing record amounts of fentanyl at the border. Plus, new synthetic opioids are emerging every year. This isn’t a shrinking problem, it’s evolving.
You don’t have to wait for a federal mandate to fix this.